Early results from the TUSCANY trial highlight promising remission rates and safety for a new triplet therapy in treating ...

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, ...

Outcomes of older patients with acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT) remain unsatisfactory. The primary objective of this trial was to ...

Updated data from the BEXMAB study reveals a significant increase in complete remission rates for patients with high-risk ...

Acute lymphoblastic leukemia (ALL) is a cancer that spreads quickly and can be fatal; it needs to be diagnosed as soon as possible. This study presents a deep learning approach for automatic ALL ...

Scientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia (AML) have found that a type of treatment—immunotherapy—may help change the environment where cancer ...

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from cancer.

However, its specific role and molecular mechanisms in acute myeloid leukemia (AML) remain largely unexplored. Methods: To identify key genes associated with AML, we analyzed gene expression profiles ...

While lineage switching has been historically associated with conventional chemotherapy regimens, emerging evidence confirms its occurrence following blinatumomab treatment, with the most common ...